- Home
- BTI vs BMY Comparison
BTI vs BMY Comparison
Compare BTI & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTI | BMY |
|---|---|---|
| Founded | 1902 | 1887 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.7B | 114.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BTI | BMY |
|---|---|---|
| Price | $60.24 | $60.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $62.00 | $59.93 |
| AVG Volume (30 Days) | 4.7M | ★ 13.5M |
| Earning Date | 02-12-2026 | 02-05-2026 |
| Dividend Yield | ★ 5.12% | 4.15% |
| EPS Growth | N/A | N/A |
| EPS | 1.89 | ★ 3.46 |
| Revenue | $35,067,817,512.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $0.27 | N/A |
| Revenue Next Year | $3.18 | N/A |
| P/E Ratio | $32.42 | ★ $17.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.31 | $42.52 |
| 52 Week High | $63.03 | $63.33 |
Technical Indicators
Market Signals| Indicator | BTI | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 55.21 | 69.89 |
| Support Level | $59.69 | $54.21 |
| Resistance Level | $63.03 | $62.05 |
| Average True Range (ATR) | 0.96 | 1.31 |
| MACD | 0.07 | 0.55 |
| Stochastic Oscillator | 47.40 | 83.23 |
Price Performance
Historical ComparisonAbout BTI British American Tobacco Industries p.l.c. ADR
The third-largest tobacco company by volume, British American Tobacco sold 518 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.